Search - tctmd.com

Displaying 801 - 820 of 2151

Sort: Relevancy | Date

News Industry News

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

October 13, 2015

News Conference News TCT 2015

FFR Guidance Remains Safe, Valuable in More Complex Disease

October 13, 2015

News Conference News TCT 2015

Debaters Question Need for Further Stent Innovation

Todd Neale

October 13, 2015

News Conference News TCT 2015

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

October 13, 2015

News Industry News

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

October 13, 2015

News Conference News TCT 2015

Very Late Stent Thrombosis Remains an Important Clinical Target

October 12, 2015

News Industry News

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

October 12, 2015

News Conference News TCT 2015

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

October 12, 2015

News Conference News TCT 2015

Robotic Systems to Play Greater Role in Cath Lab of the Future

Todd Neale

October 12, 2015

News Industry News

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

October 12, 2015

News Conference News TCT 2015

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

October 12, 2015

News Industry News

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

October 12, 2015

News Conference News TCT 2015

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

Yael L. Maxwell

October 12, 2015

News Conference News TCT 2015

DAPT Study Subanalysis Focuses on EES Subgroup

October 12, 2015

News Conference News TCT 2015

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

October 12, 2015

News Conference News TCT 2015

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

October 12, 2015

News Conference News TCT 2015

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

October 12, 2015

News Conference News TCT 2015

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Yael L. Maxwell

October 12, 2015

Presentation TCT 2015

Update on Medtronics Spyral Global

Presenter: Farrell O. Mendelsohn, William B. White, Michael Böhm

October 11, 2015

News Conference News TCT 2015

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

October 11, 2015

Advertisement

Medical Therapy With Ranolazine Did Not Reduce Adverse Events In Patients With Persistent Untreated Heart Artery Blockages After Percutaneous Coronary Intervention

FFR Guidance Remains Safe, Valuable in More Complex Disease

Debaters Question Need for Further Stent Innovation

Current State of Percutaneous Valve Therapies for Use in Congestive HF Explored

Clinical Trial Confirms No Late Benefit For Routine Thrombus Aspiration In Stemi Patients

Very Late Stent Thrombosis Remains an Important Clinical Target

STENTYS Sirolimus-Eluting Stent Confirms Best-in-Class Performance at 3 Years(1)

Speakers Consider the Efficacy of Hemodynamic Support for Cardiogenic Shock After Acute MI

Robotic Systems to Play Greater Role in Cath Lab of the Future

Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants

LAA Closure Trials Illustrate Evolution of Devices, Trial Design

First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent

Featured Lecture Calls for Integration of New Technologies to Improve Cath Lab Care

DAPT Study Subanalysis Focuses on EES Subgroup

CoreValve Extreme Risk Pivotal Trial: Improved Benefits Confirmed After 3 Years

Boston Scientific Co-founder John Abele Recognized by TCT Career Achievement Award

BIOSOLVE-II: Novel Absorbable Scaffold Safe, Effective

ABSORB III: Novel Bioresorbable Scaffold as Good as Standard-of-Care DES

Update on Medtronics Spyral Global

Symposia Highlights Variances Between Guideline-Based, ‘Real-World’ Indications for TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content